Caseware UK (AP4) 2023.0.135 2023.0.135 2024-12-312024-12-31falsefalse122024-01-01falseTour operator activities12trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 04080294 2024-01-01 2024-12-31 04080294 2023-01-01 2023-12-31 04080294 2024-12-31 04080294 2023-12-31 04080294 c:Director2 2024-01-01 2024-12-31 04080294 d:FurnitureFittings 2024-01-01 2024-12-31 04080294 d:FurnitureFittings 2024-12-31 04080294 d:FurnitureFittings 2023-12-31 04080294 d:FurnitureFittings d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 04080294 d:OfficeEquipment 2024-12-31 04080294 d:OfficeEquipment 2023-12-31 04080294 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 04080294 d:ComputerEquipment 2024-01-01 2024-12-31 04080294 d:OwnedOrFreeholdAssets 2024-01-01 2024-12-31 04080294 d:ComputerSoftware 2024-12-31 04080294 d:ComputerSoftware 2023-12-31 04080294 d:CurrentFinancialInstruments 2024-01-01 2024-12-31 04080294 d:CurrentFinancialInstruments 2024-12-31 04080294 d:CurrentFinancialInstruments 2023-12-31 04080294 d:Non-currentFinancialInstruments 2024-01-01 2024-12-31 04080294 d:Non-currentFinancialInstruments 2024-12-31 04080294 d:Non-currentFinancialInstruments 2023-12-31 04080294 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 04080294 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 04080294 d:Non-currentFinancialInstruments d:AfterOneYear 2024-12-31 04080294 d:Non-currentFinancialInstruments d:AfterOneYear 2023-12-31 04080294 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2024-12-31 04080294 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2023-12-31 04080294 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2024-12-31 04080294 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2023-12-31 04080294 d:ShareCapital 2024-12-31 04080294 d:ShareCapital 2023-12-31 04080294 d:SharePremium 2024-12-31 04080294 d:SharePremium 2023-12-31 04080294 d:RetainedEarningsAccumulatedLosses 2024-12-31 04080294 d:RetainedEarningsAccumulatedLosses 2023-12-31 04080294 d:AcceleratedTaxDepreciationDeferredTax 2024-12-31 04080294 d:AcceleratedTaxDepreciationDeferredTax 2023-12-31 04080294 d:OtherDeferredTax 2024-12-31 04080294 d:OtherDeferredTax 2023-12-31 04080294 c:FRS102 2024-01-01 2024-12-31 04080294 c:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 04080294 c:FullAccounts 2024-01-01 2024-12-31 04080294 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 04080294 d:Subsidiary1 2024-01-01 2024-12-31 04080294 d:Subsidiary1 1 2024-01-01 2024-12-31 04080294 d:Subsidiary2 2024-01-01 2024-12-31 04080294 d:Subsidiary2 1 2024-01-01 2024-12-31 04080294 d:ComputerSoftware d:ExternallyAcquiredIntangibleAssets 2024-01-01 2024-12-31 04080294 2 2024-01-01 2024-12-31 04080294 6 2024-01-01 2024-12-31 04080294 d:ComputerSoftware d:OwnedIntangibleAssets 2024-01-01 2024-12-31 04080294 e:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: 04080294










HARGREAVES & NURSE LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024

 
HARGREAVES & NURSE LIMITED
 
 
  
ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF HARGREAVES & NURSE LIMITED
FOR THE YEAR ENDED 31 DECEMBER 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Hargreaves & Nurse Limited for the year ended 31 December 2024 which comprise  the Balance Sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

This report is made solely to the Board of Directors of Hargreaves & Nurse Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Hargreaves & Nurse Limited and state those matters that we have agreed to state to the Board of Directors of Hargreaves & Nurse Limited, as a body, in this report . To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Hargreaves & Nurse Limited and its Board of Directors, as a body, for our work or for this report. 

It is your duty to ensure that Hargreaves & Nurse Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Hargreaves & Nurse Limited. You consider that Hargreaves & Nurse Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of Hargreaves & Nurse Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



Xeinadin London Limited
 
Accountants
  
36 Old Jewry
London
EC2R 8DD
10 July 2025
Page 1

 
HARGREAVES & NURSE LIMITED
REGISTERED NUMBER: 04080294

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 4 
15,067
14,342

Tangible assets
 5 
3,608
5,429

Investments
 6 
200
200

  
18,875
19,971

Current assets
  

Debtors: amounts falling due within one year
 7 
204,936
222,739

Cash at bank and in hand
 8 
19,330
11,546

  
224,266
234,285

Creditors: amounts falling due within one year
 9 
(91,414)
(118,312)

Net current assets
  
 
 
132,852
 
 
115,973

Total assets less current liabilities
  
151,727
135,944

Creditors: amounts falling due after more than one year
 10 
(37,750)
(41,468)

Provisions for liabilities
  

Deferred tax
 12 
(561)
(948)

  
 
 
(561)
 
 
(948)

Net assets
  
113,416
93,528


Capital and reserves
  

Called up share capital 
  
146,600
146,600

Share premium account
  
2,400
2,400

Profit and loss account
  
(35,584)
(55,472)

  
113,416
93,528


Page 2

 
HARGREAVES & NURSE LIMITED
REGISTERED NUMBER: 04080294
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 10 July 2025.




H C Nurse
Director

The notes on pages 4 to 12 form part of these financial statements.

Page 3

 
HARGREAVES & NURSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Hargreaves & Nurse Limited is a private company limited by shares and is registered and incorporated in England and Wales.
The registered address of the office is: 8th Floor, Becket House, 36 Old Jewry, London, EC2R 8DD.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

 
2.2

Revenue

Turnover comprises of revenue recognised by the company in respect of package holidays and other services supplied to customers in the ordinary course of business. Revenue is taken to the profit and loss account based on the date of departure.

 
2.3

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.4

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.5

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

 
2.6

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 4

 
HARGREAVES & NURSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.8

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.9

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Page 5

 
HARGREAVES & NURSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.9
Tangible fixed assets (continued)

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Fixtures and fittings
-
25% reducing balance
Computer equipment
-
33.33% straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.10

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.11

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.12

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.13

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.14

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Deferred tax liabilities are also presented within provisions but are measured in accordance with the accounting policy on taxation.
 
Increases in provisions are generally charged as an expense to profit or loss.

Page 6

 
HARGREAVES & NURSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.15

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting. 

  
2.16

Advance holiday receipts and expenditure

All revenue relating to tours with departure dates after the year end are treated as advance receipts
at the balance sheet date and disclosed within other creditors. Payments made to suppliers in
respect of these tours are included within other debtors.


3.


Employees

The average monthly number of employees, including directors, during the year was 12 (2023 - 12).


4.


Intangible assets




Computer software

£



Cost


At 1 January 2024
15,250


Additions
2,500



At 31 December 2024

17,750



Amortisation


At 1 January 2024
908


Charge for the year on owned assets
1,775



At 31 December 2024

2,683



Net book value



At 31 December 2024
15,067



At 31 December 2023
14,342



Page 7

 
HARGREAVES & NURSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

5.


Tangible fixed assets





Fixtures and fittings
Office equipment
Total

£
£
£



Cost or valuation


At 1 January 2024
121,291
10,101
131,392



At 31 December 2024

121,291
10,101
131,392



Depreciation


At 1 January 2024
117,431
8,532
125,963


Charge for the year on owned assets
965
856
1,821



At 31 December 2024

118,396
9,388
127,784



Net book value



At 31 December 2024
2,895
713
3,608



At 31 December 2023
3,860
1,569
5,429


6.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 January 2024
200



At 31 December 2024
200




Page 8

 
HARGREAVES & NURSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

Subsidiary undertakings


The following were subsidiary undertakings of the Company:

Name

Registered office

Class of shares

Holding

Just Sardinia Limited
8th Floor Becket House, 36 Old Jewry, London, England, EC2R 8DD
Ordinary
100%
Just Skiing Limited
8th Floor Becket House, 36 Old Jewry, London, England, EC2R 8DD
Ordinary
100%


7.


Debtors

2024
2023
£
£


Other debtors
4,159
19,879

Prepayments and accrued income
200,777
202,860

204,936
222,739


Prepayments and accrued income includes advanced payments to suppliers for departures after the
balance sheet date amounting to £190,402 (2023: £192,445).


8.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
19,330
11,546

19,330
11,546


Page 9

 
HARGREAVES & NURSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

9.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank loans
3,636
5,269

Corporation tax
5,997
6,875

Other taxation and social security
5,973
6,315

Other creditors
1,045
13,574

Accruals and deferred income
74,763
86,279

91,414
118,312


Included within "Accruals and deferred income" above are amounts relating to customer monies held on
account of holidays departing after the year end the total of which amount to £70,763 (2023: £78,143).


10.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bank loans
27,750
31,468

Other creditors
10,000
10,000

37,750
41,468


Other creditors includes £10,000 that has been loaned to the company from the director and has been subordinated in accordance with the terms set out by the Civil Aviation Authority (CAA). This means the £10,000 cannot be repaid whilst the company holds and Air Travel Organisers license unless written consent has been received by the CAA.

Page 10

 
HARGREAVES & NURSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

11.


Loans


Analysis of the maturity of loans is given below:


2024
2023
£
£

Amounts falling due within one year

Bank loans
3,636
5,269


3,636
5,269

Amounts falling due 1-2 years

Bank loans
3,636
5,269


3,636
5,269

Amounts falling due 2-5 years

Bank loans
24,114
26,198


24,114
26,198


31,386
36,736


There is an outstanding fixed and floating charge securing the Natwest bank loan.


12.


Deferred taxation




2024


£






At beginning of year
(948)


Charged to profit or loss
387



At end of year
(561)

The provision for deferred taxation is made up as follows:

2024
2023
£
£


Accelerated capital allowances
(661)
(1,052)

Other short term timing differences
100
104

(561)
(948)

Page 11

 
HARGREAVES & NURSE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

13.


Pension commitments

The company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the company in an independently administered fund. The pension cost charge represents contributions payable by the company to the fund and amounted to £4,648 (2023: £5,079). Contributions totalling to £1,045 (2023: £1,041) were payable to the fund at the balance sheet date and are included in creditors.


14.


Controlling party

The company was under control of the directors by virtue of their shareholding in the company.

 
Page 12